Institutional & Family Asset Management, LLC Takeda Pharmaceutical CO LTD Transaction History

Institutional & Family Asset Management, LLC

$846 Million
Q2 2024

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$13.17 - $16.4 $737 - $918	-56 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$16.3 - $17.26 $16 - $17	1 Added 1.82%	56 $1,000
Q1 2021 May 06, 2021	BUY	$16.71 - $19.9 $919 - $1,094	55 New	55 $1,000
Q2 2020 Aug 14, 2020	SELL	$14.59 - $19.5 $1,240 - $1,657	-85 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$13.02 - $20.31 $1,106 - $1,726	85 New	85 $1,000

Others Institutions Holding TAK

# of Institutions

337

Shares Held

73.8M

Call Options Held

1.96M

Put Options Held

165K

Capital Research Global Investors Los Angeles, CA

13.1M
Shares

$178 Million
0.04% of portfolio
Morgan Stanley New York, NY

5.35M
Shares

$72.6 Million
0.01% of portfolio
Mondrian Investment Partners LTD London, X0

5.09M
Shares

$69.1 Million
1.21% of portfolio
Arrowstreet Capital, Limited Partnership Boston, MA

4.64M
Shares

$62.9 Million
0.05% of portfolio
Goldman Sachs Group Inc New York, NY

4.56M
Shares

$61.8 Million
0.01% of portfolio

View Full List

About TAKEDA PHARMACEUTICAL CO LTD

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $42.2B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

More about TAK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Institutional & Family Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Institutional & Family Asset Management, LLC with notifications on news.

Account